Latest Announcements

The NSE has requested clarification from SEL Manufacturing Company Limited regarding its financial results for the quarter ended March 31, 2026. This query pertains to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which typically deals with the submission and review of financial statements. The Exchange is awaiting the company's official response to this clarification request, indicating potential discrepancies or non-compliance in the reported financials.

The National Stock Exchange (NSE) has sought clarification from Unitech Limited regarding its financial results for the quarter ended March 31, 2026, citing Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's response to this regulatory query is currently awaited, indicating a potential issue with financial reporting or compliance.

The National Stock Exchange (NSE) has requested clarification from Enviro Infra Engineers Limited regarding its financial results for the quarter ended March 31, 2026. This clarification was sought under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's official response to this regulatory query is currently pending.

The National Stock Exchange (NSE) has requested clarification from Atcom Technologies Limited concerning its financial results for the quarter ended March 31, 2026. This request was made under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, indicating potential discrepancies or missing information in the company's financial disclosures. The company's official response to the exchange's query is currently awaited, creating uncertainty regarding the accuracy and completeness of its reported earnings.

The National Stock Exchange has requested clarification from Madhucon Projects Limited concerning its financial results for the quarter ended March 31, 2026, under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The specific nature of the query is not disclosed in this announcement. The company's official response to the exchange's clarification request is currently pending.

The National Stock Exchange (NSE) has sought clarification from Sadbhav Infrastructure Project Limited concerning its financial results for the quarter ended March 31, 2026. This request was made under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to financial reporting. The company's official response to the clarification sought by the Exchange is currently awaited.

Shilpa Medicare Limited, through its material subsidiary Shilpa Biologicals Private Ltd, has commissioned a state-of-the-art Antibody-Drug Conjugate (ADC) GMP Manufacturing Facility. This facility is one of India's few integrated sites for ADC Drug Substance production, designed to meet global regulatory standards. Leveraging Shilpa's 25-year expertise in highly potent compounds, this expansion strategically positions the company as a key Contract Development and Manufacturing Organization (CDMO) partner for global biotech and pharmaceutical companies in the high-value oncology segment.

The National Stock Exchange (NSE) has sought clarification from Mahalaxmi Fabric Mills Limited regarding its financial results for the quarter ended March 31, 2026. This query pertains to compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's response to the exchange's request for clarification is currently awaited.

The National Stock Exchange (NSE) has requested clarification from Om Freight Forwarders Limited concerning its financial results for the quarter ended March 31, 2026. This clarification is sought under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's official response to the exchange's query is currently awaited.

The NSE has sought clarification from Best Agrolife Limited regarding its financial results for the quarter ended March 31, 2026, under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's response to the exchange's request is currently awaited. This indicates a potential discrepancy or query related to the reported financial data, introducing uncertainty for investors.

Mayank Cattle Food Ltd has announced that its Board of Directors will meet on July 7, 2026, to consider and approve a proposal for the issue of bonus shares. This decision is subject to requisite approvals. Additionally, the trading window for the company's securities will be closed from June 24, 2026, to July 9, 2026, inclusive, in compliance with insider trading regulations.

Biocon Limited announced that its partner, Duopharma Biotech Berhad, secured multiple insulin contracts valued over MYR 225 million from the Ministry of Health, Malaysia. Biocon's Malaysian subsidiary, Biocon Sdn. Bhd., will supply various insulin products including recombinant human insulin, insulin glargine, and insulin aspart under these contracts, which include a three-year agreement for human insulin (~MYR 155.27 million) and two 2-year agreements for insulin glargine (~MYR 18 million) and insulin aspart (~MYR 52.5 million). This reinforces Biocon's long-standing commitment and presence in Malaysia's diabetes care market.

Biocon Limited announced that its partner, Duopharma Biotech, secured multiple insulin tenders from Malaysia's Ministry of Health, valued at over MYR 225 million. Biocon's Malaysian subsidiary will supply short-acting recombinant human insulin, insulin glargine, and insulin aspart under these contracts, which include a three-year human insulin agreement and two-year agreements for insulin glargine and aspart. This reinforces Biocon's commitment to diabetes care in Malaysia, ensuring continued access to high-quality, cost-effective insulin therapies and strengthening its market presence.

Aye Finance Limited has received an upgrade in its credit ratings from India Ratings and Research (Ind-Ra). The long-term debt instruments and issuer rating were upgraded to 'IND A+/Stable' from 'IND A/Stable', while commercial papers were upgraded to 'IND A1+' from 'IND A1'. This upgrade reflects improved capitalisation from a recent IPO, a strengthened secured loan mix, enhanced profitability buffers, and a more diversified funding profile. The ratings also acknowledge the company's focus on expanding its mortgage product portfolio.

Karur Vysya Bank announced several changes in its Senior Management Personnel, including key elevations and new appointments. Shri Ravinder Aggarwal is appointed Head of Corporate and Institutional Group. Shri Ramshankar R, the current CFO, is elevated to Chief General Manager and will transition to Chief Operating Officer (COO) and KMP from October 16, 2026. Shri Ramasamy G V is appointed as the new Chief Financial Officer (CFO) and KMP, effective September 1, 2026, following Ramshankar R's movement. Additionally, Shri Vippala Ramachandrareddy and Shri Ramu S are classified as Senior Management Personnel. These changes reflect internal succession and a strengthening of the leadership team.

Leapfrog Engineering Services Ltd's equity shares will commence trading on the Bombay Stock Exchange (BSE) effective June 24, 2026, under Scrip Code 544797. This event marks the company's official public market debut, providing liquidity and trading access for investors. The listing typically follows an Initial Public Offering (IPO), significantly enhancing the company's market visibility and its capacity to raise future capital.

Liotech Industries Ltd announced that its equity shares (Scrip Code: 544796) will be officially listed and admitted to dealings on the BSE effective June 24, 2026. This action signifies the company's entry into the public market, allowing its shares to be traded by investors. The listing typically follows an initial public offering (IPO) or other capital-raising efforts, providing liquidity to initial investors.

Diksha Polymers Ltd announced that its equity shares (Scrip Code: 544798) will be listed and admitted to dealings on the BSE, effective from June 24, 2026. This marks the company's public debut, making its shares available for trading on the stock exchange. The listing typically follows an Initial Public Offering (IPO), providing the company with access to public capital markets and enhancing its market visibility.

Max Estates Limited announced the allotment of 9,644 equity shares, each with a face value of INR 10/-, to option holders under its Employee Stock Option Plan 2023. This routine corporate action, approved by the Nomination and Remuneration Committee on June 23, 2026, resulted in a minor increase in the company's paid-up equity share capital from INR 1,63,48,76,260 to INR 1,63,49,72,700.

Tech Mahindra Limited has informed shareholders about the dispatch of its Integrated Annual Report for FY 2025-26 and the Notice for its 39th Annual General Meeting (AGM), scheduled for July 17, 2026, via virtual conferencing. The company has provided exact weblinks, paths, and QR codes for accessing these documents for shareholders whose email addresses are not registered. Additionally, the announcement highlights the "Saksham Niveshak - 100 days Campaign" for unclaimed dividends and a special window for dematerialization of physical shares. This is a standard compliance filing under SEBI Listing Regulations.